Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis C

Free Subscription 18.02.2019 1 Dig Dis Sci 2 J Hepatol 1 J Infect Dis 1 J Med Virol 4 J Viral Hepat 2 Lancet 2 N Engl J Med 4 PLoS One 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Dig Dis Sci

1. WU T, Konyn PG, Cattaneo AW, Saab S, et al
   New Face of Hepatitis C.
   Dig Dis Sci. 2019 Feb 13. pii: 10.1007/s10620-019-05511.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

2. BANDA DH, Perin PM, Brown RJP, Todt D, et al
   A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors.
   J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30110.
   PubMed     Text format     Abstract available
   
   
3. KEMMING J, Reeves E, Nitschke K, Widmeier V, et al
   ERAP1 allotypes impact the epitope repertoire of virus-specific CD8(+) T cell responses in acute hepatitis C virus infection.
   J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30111.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

4. SALAZAR-VIZCAYA L, Kouyos RD, Metzner KJ, Caraballo Cortes K, et al
   Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era.
   J Infect Dis. 2019 Feb 13. pii: 5318573. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Med Virol

5. HETTA HF, Zahran AM, Mansor SG, Abdel-Malek MO, et al
   Frequency and Implications of Myeloid Derived Suppressor Cells and Lymphocyte Subsets in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
   J Med Virol. 2019 Feb 13. doi: 10.1002/jmv.25428.
   PubMed     Text format     Abstract available
   
   

   
   J Viral Hepat

6. PALAZZO D, Biliotti E, Esvan R, Volpicelli L, et al
   Vitamin D deficiency and health-related quality of life in chronic hepatitis C.
   J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13076.
   PubMed     Text format     Abstract available
   
   
7. FERENCI P, Bourgeois S, Buggisch P, Norris S, et al
   Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observation
   J Viral Hepat. 2019 Feb 10. doi: 10.1111/jvh.13080.
   PubMed     Text format     Abstract available
   
   
8. LAWITZ E, Poordad F, Anderson LJ, Vesay M, et al
   Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection.
   J Viral Hepat. 2019 Feb 9. doi: 10.1111/jvh.13079.
   PubMed     Text format     Abstract available
   
   
9. IDILMAN R, Demir M, Aladag M, Erol C, et al
   Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort.
   J Viral Hepat. 2019 Feb 11. doi: 10.1111/jvh.13075.
   PubMed     Text format     Abstract available
   
   

   
   Lancet

10. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    PubMed     Text format     Abstract available
    
    
11. HOLMES JA, Rutledge SM, Chung RT
    Direct-acting antiviral treatment for hepatitis C.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32326.
    PubMed     Text format    
    
    

    
    N Engl J Med

12. MOON S, Erickson E
    Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C.
    N Engl J Med. 2019;380:607-610.
    PubMed     Text format    
    
    
13. DA FONSECA EM, Shadlen K, Bastos FI
    Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.
    N Engl J Med. 2019;380:605-607.
    PubMed     Text format    
    
    

    
    PLoS One

14. HANSEN JF, Christiansen KM, Staugaard B, Moessner BK, et al
    Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C.
    PLoS One. 2019;14:e0212036.
    PubMed     Text format     Abstract available
    
    
15. YANG RF, Liu Y, Zhao CY, Ding YX, et al
    A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?
    PLoS One. 2019;14:e0211795.
    PubMed     Text format     Abstract available
    
    
16. ARENDS RM, Nelwan EJ, Soediro R, van Crevel R, et al
    Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study.
    PLoS One. 2019;14:e0207970.
    PubMed     Text format     Abstract available
    
    
17. ABEL S, Cuzin L, Da Cunha S, Bolivard JM, et al
    Reaching the WHO target of testing persons in jails in prisons will need diverse efforts and resources.
    PLoS One. 2018;13:e0202985.
    PubMed     Text format     Abstract available
    
    

    
    Virology

18. SUZUKI R, Matsuda M, Shimoike T, Watashi K, et al
    Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.
    Virology. 2019;529:226-233.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: